EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Clinical trial NCT05688241 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05688241
Sponsor: University Hospital, Basel, Switzerland
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EBV Lymphoma Post-transplant Lymphoproliferative Disease (PTLD)

Start date: 2026-11-01
Primary completion: 2031-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.